BioLineRx Ltd. (NASDAQ: BLRX) to release Q4 earnings on March 23. Previous Q3 losses were 22 cents per share, with sales of $427,000. Analysts rate the stock favorably.
Importance Rank:
1
BUILT ON A CARBON NEUTRAL BLOCKCHAIN NETWORK
© MegaHoot, LLC. All Rights Reserved | media at hootdex.com | Privacy Policy | Risk Disclosure | Legal Disclaimer | TOS | Neutrality | AML/KYC